Literature DB >> 5903164

The effects of peritoneal dialysis on the physiological disposition of oxacillin, ampicillin and tetracycline in patients with renal disease.

J Ruedy.   

Abstract

Seven patients with acute or chronic renal failure who were receiving intermittent peritoneal dialysis and who required parenteral oxacillin, ampicillin or tetracycline were studied to determine the disposition of these antibiotics in severe renal disease and the effects of peritoneal dialysis. While severe renal impairment markedly prolongs persistence in the serum of ampicillin and tetracycline, there is little effect on oxacillin. Whereas required doses of ampicillin and tetracycline are lower in the presence of severe renal disease, oxacillin should be given in doses equivalent to those used for patients with normal renal function. Peritoneal dialysis does not alter these dosage requirements.Four patients receiving ampicillin or tetracycline in the infusing solution during peritoneal dialysis were studied to determine the amount of systemic absorption. Local prophylaxis alone is not achieved with this method of administration, since small amounts of both antibiotics are absorbed systemically from the infusing solution. The serum concentration of tetracycline attained is inadequate for treatment of systemic infections but is probably significant, with repeated use in intermittent dialysis, in causing adverse effects. Tetracycline should be abandoned in the local prophylaxis of peritonitis during peritoneal dialysis.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5903164      PMCID: PMC1935278     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  6 in total

1.  PERITONEAL TRANSPORT OF ANTIBIOTICS IN MAN.

Authors:  L SHEAR; J H SHINABERGER; K G BARRY
Journal:  N Engl J Med       Date:  1965-04-01       Impact factor: 91.245

Review 2.  PERITONEAL DIALYSIS. CURRENT STATUS AND FUTURE APPLICATIONS.

Authors:  K G BARRY; F D SCHWARTZ
Journal:  Pediatr Clin North Am       Date:  1964-08       Impact factor: 3.278

3.  Demethylchlortetracycline; a new tetracycline antibiotic that yields greater and more sustained antibacterial activity.

Authors:  C M KUNIN; M FINLAND
Journal:  N Engl J Med       Date:  1958-11-20       Impact factor: 91.245

4.  Persistence of antibiotics in blood of patients with acute renal failure. III. Penicillin, streptomycin, erythromycin and kanamycin.

Authors:  C M KUNIN; M FINLAND
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

5.  Persistence of antibiotics in blood of patients with acute renal failure. I. Tetracycline and chlortetracycline.

Authors:  C M KUNIN; S B REES; J P MERRILL; M FINLAND
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

6.  Persistence of antibiotics in blood of patients with acute renal failure. II. Chloramphenicol and its metabolic products in the blood of patients with severe renal disease or hepatic cirrhosis.

Authors:  C M KUNIN; A J GLAZKO; M FINLAND
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

  6 in total
  10 in total

1.  Effect of peritoneal dialysis on serum levels of tobramycin and clindamycin.

Authors:  R F Malacoff; F O Finkelstein; V T Andriole
Journal:  Antimicrob Agents Chemother       Date:  1975-11       Impact factor: 5.191

Review 2.  Drug therapy in patients undergoing peritoneal dialysis. Clinical pharmacokinetic considerations.

Authors:  T W Paton; W R Cornish; M A Manuel; B G Hardy
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447

3.  Effects of impaired renal function, hemodialysis, and peritoneal dialysis on the pharmacokinetics of mezlocillin.

Authors:  D Kampf; R Schurig; K Weihermüller; D Förster
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

4.  A clinical trial of cephaloridine.

Authors:  J Ruedy
Journal:  Can Med Assoc J       Date:  1966-06-25       Impact factor: 8.262

Review 5.  Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Authors:  W L St Peter; K A Redic-Kill; C E Halstenson
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

6.  Lack of bactericidal antagonism or synergism in vitro between oxacillin and vancomycin against methicillin-susceptible strains of Staphylococcus aureus.

Authors:  Christian Joukhadar; Satish Pillai; Christine Wennersten; Robert C Moellering; George M Eliopoulos
Journal:  Antimicrob Agents Chemother       Date:  2009-11-23       Impact factor: 5.191

7.  Comparative penetration of amikacin, gentamicin, and penicillin g into exudate fluid in experimental sterile peritonitis.

Authors:  R R MacGregor
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

8.  Absorption of antibiotics during peritoneal dialysis in patients with renal failure.

Authors:  A C Buck; S L Cohen
Journal:  J Clin Pathol       Date:  1968-01       Impact factor: 3.411

9.  Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of haemodialysis and peritoneal dialysis.

Authors:  H Merdjan; A Baumelou; B Diquet; O Chick; E Singlas
Journal:  Br J Clin Pharmacol       Date:  1985-02       Impact factor: 4.335

10.  Differences in kinetic properties of drugs: implications as to the selection of a particular drug for use in patients with renal failure with special emphasis on antibiotics and beta-adrenoceptor blocking agents.

Authors:  J Fabre; H M Fox; P Dayer; L Balant
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.